PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35439707-7	2022	The docking simulation results predicted that (+)-dihydrokaempferol, (+)- dihydroquercetin, (+)-dihydromyricetin, kaempferol, quercetin, myricentin, isoquercitrin, and rutin could bind to at least two subsites (S1, S1", S2, and S4) in the binding pocket and inhibit the activity of SARS-CoV-2 Mpro.	Quercetin	126-135	NEWENTRY	Severe acute respiratory syndrome-related coronavirus	293-297	
34821532-9	2021	Quercetin binding to Mpro altered the thermostability of the viral protein through redox-based mechanism and inhibited the viral enzymatic activity.	Quercetin	0-9	NEWENTRY	Severe acute respiratory syndrome-related coronavirus	21-25	
34821532-10	2021	Interaction of quercetin-derivatives with the Mpro seem to be influenced by the 7-OH group and the acetoxylation of sugar moiety on the ligand molecule.	Quercetin	15-24	NEWENTRY	Severe acute respiratory syndrome-related coronavirus	46-50	
34278965-9	2021	Considering molecular docking, simulation, and DFT analysis of the selected compounds, notably eriodictoyl, quercetin, and diosmetin showed good potential against SARS-CoV-2 Mpro.	Quercetin	108-117	NEWENTRY	Severe acute respiratory syndrome-related coronavirus	174-178	
33158717-10	2021	Quercetin, wogonin, and polydatin bind directly to the main protease (Mpro) of SARS-CoV-2.	Quercetin	0-9	NEWENTRY	Severe acute respiratory syndrome-related coronavirus	70-74	
33457176-4	2021	Present study deals with in silico allosteric inhibition analysis of quercetin, against SARS-CoV-2-Mpro.	Quercetin	69-78	NEWENTRY	Severe acute respiratory syndrome-related coronavirus	99-103	
33457176-5	2021	Molecular docking of quercetin with Mpro revealed consistent binding of quercetin at a site other than active site in multiple runs, with the highest binding energy of - 8.31 kcal/mol, forming 6 H-bonds with residues Gln127, Cys128, Lys137, Asp289 and Glu290.	Quercetin	21-30	NEWENTRY	Severe acute respiratory syndrome-related coronavirus	36-40	
33457176-5	2021	Molecular docking of quercetin with Mpro revealed consistent binding of quercetin at a site other than active site in multiple runs, with the highest binding energy of - 8.31 kcal/mol, forming 6 H-bonds with residues Gln127, Cys128, Lys137, Asp289 and Glu290.	Quercetin	72-81	NEWENTRY	Severe acute respiratory syndrome-related coronavirus	36-40	
33457176-6	2021	Molecular dynamic simulation of 50 ns revealed high stability of Mpro-quercetin complex with RMSD values ranging from 0.1 to 0.25 nm.	Quercetin	70-79	NEWENTRY	Severe acute respiratory syndrome-related coronavirus	65-69	
33457176-7	2021	Moreover, native-Mpro and Mpro-quercetin complex conformations extracted at different time points from simulation trajectories were subjected to active site-specific docking with modelled substrate peptide (AVLQSGFR) by ZDOCK server.	Quercetin	31-40	NEWENTRY	Severe acute respiratory syndrome-related coronavirus	26-30	
33457176-9	2021	While substrate peptide remained intact when docked with Mpro-quercetin complex, also the binding energy of peptide reduced from 785 to 86 from 1 to 50 ns as quercetin induced alterations in the active site cavity reducing its affinity for the substrate.	Quercetin	62-71	NEWENTRY	Severe acute respiratory syndrome-related coronavirus	57-61	
33457176-9	2021	While substrate peptide remained intact when docked with Mpro-quercetin complex, also the binding energy of peptide reduced from 785 to 86 from 1 to 50 ns as quercetin induced alterations in the active site cavity reducing its affinity for the substrate.	Quercetin	158-167	NEWENTRY	Severe acute respiratory syndrome-related coronavirus	57-61	
33457176-11	2021	Hence, quercetin displayed effective allosteric inhibition potential against SARS-CoV-2 Mpro, and can be developed into an efficient treatment for COVID-19.	Quercetin	7-16	NEWENTRY	Severe acute respiratory syndrome-related coronavirus	88-92	
34208928-0	2021	Seleno-Functionalization of Quercetin Improves the Non-Covalent Inhibition of Mpro and Its Antiviral Activity in Cells against SARS-CoV-2.	Quercetin	28-37	NEWENTRY	Severe acute respiratory syndrome-related coronavirus	78-82	
34208928-3	2021	The natural flavonoid quercetin 1 has been recently reported to be a potent Mpro inhibitor in vitro, and we explored the effect produced by the introduction of organoselenium functionalities in this scaffold.	Quercetin	22-31	NEWENTRY	Severe acute respiratory syndrome-related coronavirus	76-80	
35624740-7	2022	The literature reveals that quercetin exhibits anti-COVID-19 activity because of its inhibitory effect on the expression of the human ACE2 receptors and the enzymes of SARS-CoV-2 (MPro, PLPro, and RdRp).	Quercetin	28-37	NEWENTRY	Severe acute respiratory syndrome-related coronavirus	180-184